Targeting silibinin in the antiproliferative pathway
Authors:
- Jin ZengJin Zeng
- Ye GaoYGYe Gao
- Dalin HeDHDalin He
- 5 January 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 19 (2) , 243-255
Abstract
(2010). Targeting silibinin in the antiproliferative pathway. Expert Opinion on Investigational Drugs: Vol. 19, No. 2, pp. 243-255. doi: 10.1517/13543780903533631Keywords
This publication has 91 references indexed in Scilit:
- Multitargeted therapy of cancer by silymarinCancer Letters, 2008
- Silymarin and epithelial cancer chemoprevention: How close we are to bedside?Toxicology and Applied Pharmacology, 2007
- Multiple molecular mechanisms for multidrug resistance transportersNature, 2007
- Silybin and Silymarin - New and Emerging Applications in MedicineCurrent Medicinal Chemistry, 2007
- Mechanisms and preclinical efficacy of silibinin in preventing skin cancerEuropean Journal of Cancer, 2005
- Prostate Cancer Prevention by SilibininCurrent Cancer Drug Targets, 2004
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- The Use of Silymarin in the Treatment of Liver DiseasesDrugs, 2001
- The Hallmarks of CancerCell, 2000
- Milk Thistle ( Silybum marianum ) for the Therapy of Liver DiseaseAmerican Journal of Gastroenterology, 1998